Perigraft seroma after thoracic aortic surgery

Risk factors for PGS after thoracic aortic surgery - Risk factors for PGS after thoracic aortic surger

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050764

Enrollment

100

Registered

2023-04-04

Start date

2016-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic aortic aneurysm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent either ascending aortic replacement or aortic arch replacement between 2016 and 2022 in our institution were enrolled in the present study. Fluid capsules with a diameter greater than 3.0 cm and radiodensity less than 25 Housefield units were screened to detect PGS on follow-up using computed tomography scans postoperatively. Patients requiring emergency surgery, using an elephant trunk, or redo surgery were included in this study.

Exclusion criteria

Exclusion criteria: Patients who developed deep sternal infection or PGS immediately after initial surgery (within 2 months) were excluded from the study.

Design outcomes

Primary

Measure	Time frame
pertinent factors associated with mediastinal perigraft seroma formation following thoracic aortic surgery	—

Countries

Japan

Contacts

Public ContactRyo Suzuki

Saitama Sekishinnkai Hospital Cardiovascular Surgery

ryosuzuki0722@yahoo.co.jp0429536611

Outcome results